GlucoModicum is pioneering a revolutionary new sensor, the Talisman, which measures glucose molecules diffused through your skin. This is based on unique platform magnetohydrodynamic technology that can sample interstitial fluid, the body fluid between blood vessels and cells, non-invasively, rapidly and gently. This is the first time in 25 years that a new technology category has been introduced in this space.

MHD is a physical phenomenon where fluid flow is induced by external magnetic and electric fields (Lorentz force). The same physical mechanism has been used in other biomedical applications, e.g. in micropumps and jet injectors.

This technology is the result of six years of research at the University of Helsinki from renowned scientists from across the globe and has already been peer-reviewed in Scientific Reports (a Nature publication) which showed that the performance is 13x better than previous needle-free approaches.